Precise reconstruction of the aortic valve using glutaraldehyde-treated autologous pericardium in new formula: a case report.
Humans
Male
Pericardium
/ transplantation
Adult
Glutaral
/ therapeutic use
Aortic Valve
/ surgery
Transplantation, Autologous
Aortic Valve Insufficiency
/ surgery
Plastic Surgery Procedures
/ methods
Aortic Valve Disease
/ surgery
Treatment Outcome
Echocardiography, Transesophageal
Echocardiography
Endocarditis
/ surgery
Aortic valve reconstruction
Case report
Glutaraldehyde-treated autologous pericardium
Journal
Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382
Informations de publication
Date de publication:
09 Jul 2024
09 Jul 2024
Historique:
received:
25
12
2023
accepted:
02
06
2024
medline:
9
7
2024
pubmed:
9
7
2024
entrez:
8
7
2024
Statut:
epublish
Résumé
The current study presents a novel and precise surgical technique for complete reconstruction of the aortic valve using glutaraldehyde-treated autologous pericardium in a patient with aortic valve disease and endocarditis. The technique aims to provide a more effective and reproducible method for aortic valve repair, with the goal of improving outcomes and quality of life for patients with aortic valve disease. A 35-year-old Iranian male with aortic valve disease and endocarditis underwent aortic valve reconstruction surgery. Preoperative echocardiography showed a degenerative aortic valve with severe regurgitation, reduced left ventricular ejection fraction, and specific aortic root dimensions. The surgical technique involved precise measurements and calculations to design the size and shape of the new aortic valve cusps using autologous pericardium, with the goal of optimizing coaptation and function. The surgeon calculated the intercommissural distance based on the aortic annulus diameter to determine cusp size and shape. He tailored the pericardial cusps to have a height equal to 80% of the coaptation margin length. Detailed suturing techniques were used to ensure proper alignment and coaptation of the new cusps. Intraoperative evaluation of the valve function using suction and transesophageal echocardiography showed good coaptation and minimal residual regurgitation. At the 3-year follow-up, the patient had a well-functioning aortic valve with only trivial leak and was in satisfactory clinical condition. Glutaraldehyde-treated autologous pericardium is a validated leaflet alternative, and the causes of its failure are late annular dilatation and other technique breakdowns. Current evidence reveals that aortic valve reconstruction with glutaraldehyde-treated autologous pericardium is associated with many advantages with the potential to improve patient outcomes and quality of life. Further clinical studies are warranted to evaluate the long-term durability and efficacy of this approach.
Sections du résumé
BACKGROUND
BACKGROUND
The current study presents a novel and precise surgical technique for complete reconstruction of the aortic valve using glutaraldehyde-treated autologous pericardium in a patient with aortic valve disease and endocarditis. The technique aims to provide a more effective and reproducible method for aortic valve repair, with the goal of improving outcomes and quality of life for patients with aortic valve disease.
CASE PRESENTATION
METHODS
A 35-year-old Iranian male with aortic valve disease and endocarditis underwent aortic valve reconstruction surgery. Preoperative echocardiography showed a degenerative aortic valve with severe regurgitation, reduced left ventricular ejection fraction, and specific aortic root dimensions. The surgical technique involved precise measurements and calculations to design the size and shape of the new aortic valve cusps using autologous pericardium, with the goal of optimizing coaptation and function. The surgeon calculated the intercommissural distance based on the aortic annulus diameter to determine cusp size and shape. He tailored the pericardial cusps to have a height equal to 80% of the coaptation margin length. Detailed suturing techniques were used to ensure proper alignment and coaptation of the new cusps. Intraoperative evaluation of the valve function using suction and transesophageal echocardiography showed good coaptation and minimal residual regurgitation. At the 3-year follow-up, the patient had a well-functioning aortic valve with only trivial leak and was in satisfactory clinical condition.
CONCLUSIONS
CONCLUSIONS
Glutaraldehyde-treated autologous pericardium is a validated leaflet alternative, and the causes of its failure are late annular dilatation and other technique breakdowns. Current evidence reveals that aortic valve reconstruction with glutaraldehyde-treated autologous pericardium is associated with many advantages with the potential to improve patient outcomes and quality of life. Further clinical studies are warranted to evaluate the long-term durability and efficacy of this approach.
Identifiants
pubmed: 38978082
doi: 10.1186/s13256-024-04637-6
pii: 10.1186/s13256-024-04637-6
doi:
Substances chimiques
Glutaral
T3C89M417N
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
314Informations de copyright
© 2024. The Author(s).
Références
Malaisrie SC, McCarthy PM. Surgical approach to diseases of the aortic valve and aortic root. In: Otto CM, Bonow RO, editors. Valvular heart disease: a companion to Braunwald’s heart disease. 5th ed. Philadelphia: Elsevier; 2021.
Spadaccio C, Alkhamees K, Al-Attar N. Recent advances in aortic valve replacement. F1000Research. 2019;8:1159.
doi: 10.12688/f1000research.17995.1
Brinkman WT, Williams WH, Guyton RA, Jones EL, Craver JM. Valve replacement in patients on chronic renal dialysis: implications for valve prosthesis selection. Ann Thorac Surg. 2002;74(1):37–42.
doi: 10.1016/S0003-4975(02)03692-5
pubmed: 12118800
Ozaki S, Kawase I, Yamashita H, Uchida S, Nozawa Y, Takatoh M, et al. A total of 404 cases of aortic valve reconstruction with glutaraldehyde-treated autologous pericardium. J Thorac Cardiovasc Surg. 2014;147(1):301–6.
doi: 10.1016/j.jtcvs.2012.11.012
pubmed: 23228404
Ozaki S, Kawase I, Yamashita H, Uchida S, Nozawa Y, Matsuyama T, et al. Aortic valve reconstruction using self-developed aortic valve plasty system in aortic valve disease. Interact Cardiovasc Thorac Surg. 2011;12(4):550–3.
doi: 10.1510/icvts.2010.253682
pubmed: 21273254
Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A. Valvular Heart Disease Epidemiology. Med Sci (Basel). 2022;10(2):32.
pubmed: 35736352
Sá MPBO, Perazzo ÁM, Zhigalov K, Komarov R, Kadyraliev B, Enginoev S, et al. Aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium (Ozaki Procedure)—a promising surgical technique. Braz J Cardiovasc Surg. 2019;34(5):610–4.
doi: 10.21470/1678-9741-2019-0304
pubmed: 31719012
pmcid: 6852454
Albertini A, Raviola E, Zucchetta F, Brega C, Mikus E, Tripodi A. Aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium to avoid the prosthesis-patient mismatch of a severely obese 57-year-old patient—a case report. J Vis Surg. 2022;8:24.
doi: 10.21037/jovs-20-110
Kawase I, Ozaki S, Yamashita H, Uchida S, Nozawa Y, Matsuyama T, et al. Aortic valve reconstruction with autologous pericardium for dialysis patients. Interact Cardiovasc Thorac Surg. 2013;16(6):738–42.
doi: 10.1093/icvts/ivt033
pubmed: 23427312
pmcid: 3653458
Björk VO, Hultquist G. Teflon and pericardial aortic valve prostheses. J Thorac Cardiovasc Surg. 1964;47(6):693–701.
doi: 10.1016/S0022-5223(19)33497-X
Al Halees Z, Al Shahid M, Al Sanei A, Sallehuddin A, Duran C. Up to 16 years follow-up of aortic valve reconstruction with pericardium: a stentless readily available cheap valve? Eur J Cardiothorac Surg. 2005;28(2):200–5.
doi: 10.1016/j.ejcts.2005.04.041
pubmed: 16039963
Ozaki S, Kawase I, Yamashita H, Uchida S, Takatoh M, Hagiwara S, et al. Aortic valve reconstruction using autologous pericardium for aortic stenosis. Circulation. 2015;79(7):1504–10.
doi: 10.1253/circj.CJ-14-1092